ANDREW TERHUNE: Open Payments
NPI 1518316405 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 28 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $332 |
| GENZYME CORPORATION | 6 | $175 |
| Verona Pharma, Inc. | 1 | $116 |
| PFIZER INC. | 1 | $97 |
| LEO Pharma Inc. | 1 | $78 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| Incyte Corporation | 3 | $55 |
| CSL Behring | 2 | $40 |
| Grifols USA, LLC | 1 | $25 |
| Amgen Inc. | 1 | $14 |
Products named: FASENRA, TEZSPIRE, Ohtuvayre, CIBINQO, ANZUPGO, DUPIXENT, OPZELURA, NUCALA.
Industry payments across CA — which companies pay providers there.
